Clearline Capital LP Heron Therapeutics, Inc. Transaction History

Clearline Capital LP

$1.53 Billion
Q1 2025

A detailed history of Clearline Capital LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Clearline Capital LP holds 1,059,911 shares of HRTX stock, worth $2.33 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,059,911

Previous 1,810,483 41.46%

Holding current value

$2.33 Million

Previous $2.77 Million 15.85%

% of portfolio

0.15%

Previous 0.4%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.47 - $2.55 $1.1 Million - $1.91 Million	-750,572 Reduced 41.46%	1,059,911 $2.33 Million
Q4 2024 Feb 14, 2025	SELL	$1.06 - $2.12 $440,990 - $881,981	-416,029 Reduced 18.69%	1,810,483 $2.77 Million
Q3 2024 Nov 14, 2024	BUY	$1.73 - $3.67 $1.27 Million - $2.68 Million	731,246 Added 48.9%	2,226,512 $4.43 Million
Q2 2024 Aug 14, 2024	SELL	$2.32 - $3.86 $2.97 Million - $4.94 Million	-1,280,938 Reduced 46.14%	1,495,266 $5.23 Million
Q1 2024 May 15, 2024	SELL	$1.71 - $3.06 $5.63 Million - $10.1 Million	-3,292,350 Reduced 54.25%	2,776,204 $7.69 Million
Q4 2023 Feb 14, 2024	SELL	$0.54 - $1.82 $43,895 - $147,944	-81,288 Reduced 1.32%	6,068,554 $10.3 Million
Q3 2023 Nov 14, 2023	BUY	$0.97 - $1.8 $3.38 Million - $6.27 Million	3,483,858 Added 130.68%	6,149,842 $6.33 Million
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.88 $640,128 - $1.66 Million	576,692 Added 27.6%	2,665,984 $3.09 Million
Q1 2023 May 15, 2023	BUY	$1.51 - $3.25 $1.61 Million - $3.46 Million	1,064,510 Added 103.88%	2,089,292 $3.15 Million
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $2.31 Million - $4.79 Million	1,024,782 New	1,024,782 $2.56 Million
Q2 2020 Aug 14, 2020	SELL	$10.89 - $21.47 $519,093 - $1.02 Million	-47,667 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $487,633 - $1.17 Million	47,667 New	47,667 $560,000
Q3 2019 Nov 14, 2019	SELL	$16.36 - $21.39 $276,811 - $361,918	-16,920 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $379,502 - $587,747	-22,416 Reduced 56.99%	16,920 $315,000
Q4 2018 Feb 14, 2019	BUY	$22.03 - $32.01 $188,951 - $274,549	8,577 Added 27.88%	39,336 $1.02 Million
Q3 2018 Nov 14, 2018	BUY	$30.0 - $40.85 $922,770 - $1.26 Million	30,759 New	30,759 $974,000

Others Institutions Holding HRTX

# of Institutions

182

Shares Held

125M

Call Options Held

847K

Put Options Held

47.7K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $261M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Clearline Capital LP with notifications on news.

Account

Clearline Capital LP Heron Therapeutics, Inc. Transaction History